AU
UK
CA
NZ
IND
US
ACM Research, Inc. (NASDAQ: ACMR)designs, manufactures, and markets semiconductor process equipment, including tools for cleaning, electroplating, stress-free polishing, vertical furnace operations, track systems, plasma-enhanced chemical vapor deposition (PECVD), as well as wafer- and panel-level packaging. These solutions support both advanced and semi-critical semiconductor device …
In 2025, several NASDAQ-listed companies have delivered high year-to-date returns. Many draw strength from AI, cloud, memory/semi-equipment, or commercial software platforms. Below are recent financial updates for two of the leading names (Palantir, Micron), visible performance rankings, and key trends to observe.
Through mid-September 2025, several Dow Jones components have significantly outperformed their peers. Performance has been shaped by a mix of macroeconomic trends—including interest rates, sector‐specific demand (for example in finance, technology, and industrials), and regulatory or trade headwinds. Below are several companies that have …
The year 2025 is shaping into a defining period for technology companies listed on the NASDAQ. Artificial intelligence, cloud computing, cybersecurity, and semiconductors remain at the forefront of revenue growth and capital allocation. With corporate earnings from the second quarter of 2025 and early …
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NASDAQ: SNY | EURONEXT: SAN) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent® (dupilumab) in the European Union for the treatment of …
TransMedics Group, Inc. (Nasdaq:TMDX), a medical technology company focused on organ transplant therapy, announced a strategic collaboration with Mercedes-Benz Group AG to introduce a fleet of purpose-built Mercedes-Benz V-Class vehicles dedicated to organ transportation across Italy. This initiative aligns with TransMedics’ plan to replicate …
Wall Street Zen downgraded shares of Pearson plc (NYSE:PSO) from a “Buy” rating to a “Hold” rating in a research note issued on Saturday. The revision comes amid recent mixed analyst coverage, with some firms maintaining more cautious positions while others have upgraded the …
Index Update
Index Update
Skye Bioscience, Inc. (Nasdaq:SKYE), a clinical-stage biotechnology company developing therapies for obesity and metabolic health disorders, presented results from its Phase 1b study of nimacimab at the European Association for the Study of Diabetes (EASD) Annual Meeting. The trial evaluated nimacimab in subjects with …
Please wait processing your request...